Macquarie Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.69M Hold
180,000
﹤0.01% 1269
2025
Q1
$2.21M Hold
180,000
﹤0.01% 1187
2024
Q4
$2.38M Sell
180,000
-63,352
-26% -$838K ﹤0.01% 1149
2024
Q3
$4.69M Buy
243,352
+433
+0.2% +$8.34K 0.01% 976
2024
Q2
$4.99M Sell
242,919
-73
-0% -$1.5K 0.01% 973
2024
Q1
$5.78M Sell
242,992
-1,098
-0.4% -$26.1K 0.01% 926
2023
Q4
$5.28M Buy
244,090
+11,624
+5% +$251K 0.01% 953
2023
Q3
$3.38M Buy
232,466
+1,023
+0.4% +$14.9K ﹤0.01% 1023
2023
Q2
$4.84M Buy
231,443
+51,443
+29% +$1.08M 0.01% 937
2023
Q1
$3.8M Hold
180,000
﹤0.01% 985
2022
Q4
$4.58M Hold
180,000
0.01% 998
2022
Q3
$4.35M Sell
180,000
-991
-0.5% -$23.9K 0.01% 1018
2022
Q2
$3.48M Hold
180,991
﹤0.01% 1131
2022
Q1
$3.15K Hold
180,991
﹤0.01% 1243
2021
Q4
$3.96M Hold
180,991
﹤0.01% 1177
2021
Q3
$3.46M Hold
180,991
﹤0.01% 1205
2021
Q2
$3.11M Hold
180,991
﹤0.01% 1279
2021
Q1
$4.05M Buy
180,991
+991
+0.6% +$22.2K 0.01% 964
2020
Q4
$4M Hold
180,000
0.01% 923
2020
Q3
$2.66M Hold
180,000
﹤0.01% 967
2020
Q2
$2.67M Hold
180,000
﹤0.01% 930
2020
Q1
$1.98M Hold
180,000
﹤0.01% 913
2019
Q4
$1.58M Hold
180,000
﹤0.01% 1104
2019
Q3
$1.35M Hold
180,000
﹤0.01% 1135
2019
Q2
$1.68M Hold
180,000
﹤0.01% 1066
2019
Q1
$945K Hold
180,000
﹤0.01% 1206
2018
Q4
$801K Hold
180,000
﹤0.01% 1209
2018
Q3
$1.45M Hold
180,000
﹤0.01% 1110
2018
Q2
$1.26M Buy
+180,000
New +$1.26M ﹤0.01% 1123
2018
Q1
Sell
-1,200
Closed -$11K 2344
2017
Q4
$11K Buy
+1,200
New +$11K ﹤0.01% 2252